Germline Whole-Genome Sequencing in Early-Onset Pediatric Solid Tumors Implicates Novel Risk Factors ERRFI1 mutations represent actionable biomarkers in BTC, with EGFR-targeted therapy demonstrating ...
Beyond-line immunotherapy in ES-SCLC: Efficacy and safety of second-line PD-1/PD-L1 inhibitors after progression on first-line PD-1/PD-L1 inhibitors plus platinum-etoposide chemotherapy. This is an ...
Immune-based therapies have revolutionized cancer treatments. Cardiovascular sequelae from these treatments, however, have emerged as critical complications, representing new challenges in ...
If nonpersistence were unavoidable—for example, if patients stopped statins for good reason or if physicians discontinued statins for good reason, such as causally related adverse effects—there might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results